Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
IRMD 
Iradimed Co (IRMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: IRMD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $73.5
1 Year Target Price $73.5
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 10.87% | Avg. Invested days 43 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 906.55M USD | Price to earnings Ratio 44.27 | 1Y Target Price 73.5 |
Price to earnings Ratio 44.27 | 1Y Target Price 73.5 | ||
Volume (30-day avg) 2 | Beta 1.03 | 52 Weeks Range 46.33 - 74.43 | Updated Date 09/14/2025 |
52 Weeks Range 46.33 - 74.43 | Updated Date 09/14/2025 | ||
Dividends yield (FY) 0.89% | Basic EPS (TTM) 1.61 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 26.61% | Operating Margin (TTM) 33.26% |
Management Effectiveness
Return on Assets (TTM) 15.15% | Return on Equity (TTM) 23.75% |
Valuation
Trailing PE 44.27 | Forward PE 35.59 | Enterprise Value 853558761 | Price to Sales(TTM) 11.68 |
Enterprise Value 853558761 | Price to Sales(TTM) 11.68 | ||
Enterprise Value to Revenue 10.99 | Enterprise Value to EBITDA 34.69 | Shares Outstanding 12720000 | Shares Floating 7171537 |
Shares Outstanding 12720000 | Shares Floating 7171537 | ||
Percent Insiders 36.81 | Percent Institutions 59.44 |
Upturn AI SWOT
Iradimed Co
Company Overview
History and Background
IRADIMED CORPORATION was founded in 1980. It designs, manufactures, and markets Magnetic Resonance Imaging (MRI) compatible products, including IV infusion pump systems, patient vital signs monitoring systems, and other accessories.
Core Business Areas
- MRI-Compatible IV Infusion Pump Systems: IRADIMEDu2019s flagship product. It provides safe and precise delivery of fluids and medications to patients during MRI procedures.
- MRI-Compatible Patient Vital Signs Monitoring Systems: These systems continuously monitor patients' vital signs, such as heart rate, blood pressure, and oxygen saturation, in the MRI environment.
Leadership and Structure
Irad Hardy is the Founder, Chairman, President, and Chief Executive Officer. The company operates with a functional organizational structure focused on engineering, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- MRidium MRI IV Infusion Pump System: A non-magnetic IV infusion pump system designed for use within the MRI environment. No exact market share data available, but it is considered a leading product in its niche. Competitors are smaller companies offering similar specialized devices, often with less established market presence and potentially larger medical device companies also developing competing products.
- IRADIMED 3880 MRI Patient Monitoring System: Monitors vital signs of patients in the MRI environment. No exact market share data available, but is a major player in the MRI compatible vital signs monitoring system. Main competitors are Philips and GE Healthcare.
Market Dynamics
Industry Overview
The MRI-compatible medical device market is a specialized niche within the broader medical device industry. It's driven by the need for safe and effective patient care during MRI procedures, which are increasingly common.
Positioning
Iradimed is a leader in the MRI-compatible medical device niche, with a reputation for quality and innovation. It has a strong first-mover advantage and a dedicated focus on MRI compatibility.
Total Addressable Market (TAM)
The TAM for MRI-compatible devices is estimated to be in the hundreds of millions of dollars. Iradimed is well-positioned to capture a significant portion of this TAM due to its established presence and specialized product offerings.
Upturn SWOT Analysis
Strengths
- First-mover advantage in MRI-compatible devices
- Strong brand reputation
- Specialized product portfolio
- Proprietary technology
Weaknesses
- High concentration of revenue from a few key products
- Reliance on a niche market
- Relatively small size compared to major medical device companies
Opportunities
- Expansion into new MRI-compatible product lines
- Growth in emerging markets
- Partnerships with MRI manufacturers
- Increased adoption of MRI procedures
Threats
- Competition from larger medical device companies
- Technological advancements that could render existing products obsolete
- Changes in regulatory requirements
- Economic downturns affecting hospital budgets
Competitors and Market Share
Key Competitors
- GE (GE)
- Philips (PHG)
- Siemens (SIE.DE)
Competitive Landscape
Iradimed enjoys a competitive advantage in the MRI-compatible niche due to its early entry and specialized expertise. However, larger medical device companies such as GE, Philips, and Siemens possess significantly greater resources and broader product portfolios.
Growth Trajectory and Initiatives
Historical Growth: Discuss Iradimed Co's growth trends over the past years.
Future Projections: Provide projections for Iradimed Co's future growth based on analyst estimates.
Recent Initiatives: Highlight recent strategic initiatives undertaken by Iradimed Co.
Summary
Iradimed is a leader in the specialized MRI-compatible medical device market, demonstrating a strong focus on niche products with a first mover advantage. The company's reliance on a limited number of products and a relatively small market presence pose some risk. Strategic initiatives and continued innovation are crucial for sustained growth. Competitors with deeper pockets and broad product portfolios could also present future hurdles.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Reports
- Analyst Estimates
Disclaimers:
The information provided is for informational purposes only and should not be considered as financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Market data and analyst estimates are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Iradimed Co
Exchange NASDAQ | Headquaters Winter Springs, FL, United States | ||
IPO Launch date 2014-07-16 | Founder, Chairman, CEO & President Mr. Roger E. Susi | ||
Sector Healthcare | Industry Medical Devices | Full time employees 160 | Website https://www.iradimed.com |
Full time employees 160 | Website https://www.iradimed.com | ||
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.